Approved novel drugs in breakthrough therapy programs

Number of approved novel drugs that participated in breakthrough therapy programs during clinical development.

Unit Count Industry Pharmaceuticals

Records
1
Regions
1
Period
2024
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

Approved novel drugs in breakthrough therapy programs

China, 2024

1 observation
13 China · 2024 · NMPA · full record
Source: NMPA · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2024

Approved novel drugs in breakthrough therapy programs: every record, grouped by region, newest first.
Period Value Source Type
China 1 record
2024 13 NMPA · 31 Dec 2024 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
China approves 48 innovative drugs in 2024 NMPA 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Approved novel drugs in breakthrough therapy programs. Retrieved from https://statorigin.org/indicators/approved-novel-drugs-in-breakthrough-therapy-programs